ACUTE OVARIAN RESPONSES TO A LONG-ACTING AGONIST OF GONADOTROPIN-RELEASING HORMONE IN OVULATORY WOMEN AND WOMEN WITH POLYCYSTIC OVARIAN DISEASE

被引：0
|
作者：
DEFAZIO, J
MELDRUM, DR
LU, JKH
VALE, WW
RIVIER, JE
JUDD, HL
CHANG, RJ
机构：
[1] UNIV CALIF LOS ANGELES,SCH MED,CTR HLTH SCI 221778DEPT OBSTET & GYNECOL,DIV REPROD ENDOCRINOL,LOS ANGELES,CA 90024
[2] SALK INST BIOL STUDIES,PEPTIDE BIOL LAB,LA JOLLA,CA 92037
来源：
FERTILITY AND STERILITY | 1985年 / 44卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：453 / 459
页数：7
相关论文
共 50 条
  • [21] INFLUENCE OF THE FREQUENCY OF GONADOTROPIN-RELEASING HORMONE (GNRH) ADMINISTRATION ON OVULATORY RESPONSES IN WOMEN WITH ANOVULATION
    BRINGER, J
    HEDON, B
    JAFFIOL, C
    NICOLAU, S
    GIBERT, F
    CRISTOL, P
    ORSETTI, A
    VIALA, JL
    MIROUZE, J
    [J]. FERTILITY AND STERILITY, 1985, 44 (01) : 42 - 48
  • [22] Effects of gonadotropin-releasing hormone agonist and antagonist on ovarian activity in a mouse model for polycystic ovary
    Singh, Padmasana
    Srivastava, Raj Kamal
    Krishna, Amitabh
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2016, 163 : 35 - 44
  • [23] Depression in women treated with a gonadotropin-releasing hormone agonist
    Toren, P
    Dor, J
    Mester, R
    Mozes, T
    Blumensohn, R
    Rehavi, M
    Weizman, A
    [J]. BIOLOGICAL PSYCHIATRY, 1996, 39 (05) : 378 - 382
  • [24] TREATMENT OF SEVERE ANDROGEN EXCESS DUE TO OVARIAN HYPERTHECOSIS WITH A LONG-ACTING GONADOTROPIN-RELEASING-HORMONE AGONIST
    STEINGOLD, KA
    JUDD, HL
    NIEBERG, RK
    LU, JKH
    CHANG, RJ
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1986, 154 (06) : 1241 - 1248
  • [25] GONADOTROPIN-RELEASING-HORMONE AGONIST REDUCES THE MISCARRIAGE RATE FOR PREGNANCIES ACHIEVED IN WOMEN WITH POLYCYSTIC OVARIAN SYNDROME
    HOMBURG, R
    LEVY, T
    BERKOVITZ, D
    FARCHI, J
    FELDBERG, D
    ASHKENAZI, J
    BENRAFAEL, Z
    [J]. FERTILITY AND STERILITY, 1993, 59 (03) : 527 - 531
  • [26] Is the long-acting gonadotropin-releasing hormone agonist long protocol better for patients with endometriosis undergoing IVF?
    Wang, Xiuzhu
    Li, Wenshu
    Chen, Xuemei
    Zhang, Wei
    Chu, Min
    Yin, Shuyuan
    Chu, Yongli
    Liu, Xuemei
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2023, 162 (01) : 325 - 332
  • [27] Natural autoantibodies to the gonadotropin-releasing hormone receptor in polycystic ovarian syndrome
    Sattler, Lisa-Marie
    Schniewind, Hanna A.
    Minich, Waldemar B.
    Haudum, Christoph W.
    Niklowitz, Petra
    Muenzker, Julia
    Kovacs, Gabor L.
    Reinehr, Thomas
    Obermayer-Pietsch, Barbara
    Schomburg, Lutz
    [J]. PLOS ONE, 2021, 16 (04):
  • [28] Long-acting gonadotropin-releasing hormone agonist trigger in fertility preservation cycles before chemotherapy
    Massarotti, C.
    Stigliani, S.
    Gazzo, I.
    Lambertini, M.
    Anserini, P.
    [J]. ESMO OPEN, 2023, 8 (04)
  • [29] Use of a long-acting gonadotropin-releasing hormone agonist for treatment of steroid cell tumors of the ovary
    Wang, PH
    Chao, HT
    Lee, WL
    [J]. FERTILITY AND STERILITY, 1998, 69 (02) : 353 - 355
  • [30] Half-dose, long-acting gonadotropin-releasing hormone agonist (Diphereline) is comparable with daily injections of short-acting gonadotropin-releasing hormone agonist (Suprefact) in IVF/ICSI cycles
    Tehraninejad, Ensieh Sh.
    Nekoo, Elham Azimi
    Ezabadi, Zahra
    Rashidi, Batool H.
    Amirchaghmaghi, Elham
    Matroud, Elham Pour
    [J]. ARCHIVES OF MEDICAL SCIENCE, 2010, 6 (06) : 945 - 949
12345